Is cross-species horizontal gene transfer responsible for gallbladder carcinogenesis.

Is cross-species horizontal gene transfer responsible for gallbladder carcinogenesis.

Publication date: Jul 30, 2024

Cross-species horizontal gene transfer (HGT) involves the transfer of genetic material between different species of organisms. In recent years, mounting evidence has emerged that cross-species HGT does take place and may play a role in the development and progression of diseases. Transcriptomic data obtained from patients with gallbladder cancer (GBC) was assessed for the differential expression of antisense RNAs (asRNAs). The Basic Local Alignment Search Tool (BLAST) was used for cross-species analysis with viral, bacterial, fungal, and ancient human genomes to elucidate the evolutionary cross species origins of these differential asRNAs. Functional enrichment analysis and text mining were conducted and a network of asRNAs targeting mRNAs was constructed to understand the function of differential asRNAs better. A total of 17 differentially expressed antisense RNAs (asRNAs) were identified in gallbladder cancer tissue compared to that of normal gallbladder. BLAST analysis of 15 of these asRNAs (AFAP1-AS1, HMGA2-AS1, MNX1-AS1, SLC2A1-AS1, BBOX1-AS1, ELFN1-AS1, TRPM2-AS, DNAH17-AS1, DCST1-AS1, VPS9D1-AS1, MIR1-1HG-AS1, HAND2-AS1, PGM5P4-AS1, PGM5P3-AS1, and MAGI2-AS) showed varying degree of similarities with bacterial and viral genomes, except for UNC5B-AS1 and SOX21-AS1, which were conserved during evolution. Two of these 15 asRNAs, (VPS9D1-AS1 and SLC2A1-AS1) exhibited a high degree of similarity with viral genomes (Chikungunya virus, Human immunodeficiency virus 1, Stealth virus 1, and Zika virus) and bacterial genomes including (Staphylococcus sp. , Bradyrhizobium sp. , Pasteurella multocida sp. , and, Klebsiella pneumoniae sp. ), indicating potential HGT during evolution. The results provide novel evidence supporting the hypothesis that differentially expressed asRNAs in GBC exhibit varying sequence similarity with bacterial, viral, and ancient human genomes, indicating a potential shared evolutionary origin. These non-coding genes are enriched with methylation and were found to be associated with cancer-related pathways, including the P53 and PI3K-AKT signaling pathways, suggesting their possible involvement in tumor development.

Open Access PDF

Concepts Keywords
Gallbladder Antisense RNA (asRNAs)
Genomes asRNAs targeting mRNAs
Mining Carcinogenesis
Sox21 Gallbladder cancer
Staphylococcus Gallbladder Neoplasms
Gene regulatory network
Gene Transfer, Horizontal
Humans
RNA, Antisense
RNA, Antisense
Transcriptome
Transcriptomic profiling

Semantics

Type Source Name
disease MESH inflammation
disease MESH gastrointestinal disorders
drug DRUGBANK Trestolone
disease MESH cancer
pathway REACTOME Methylation
drug DRUGBANK Tropicamide
disease MESH gallbladder cancer
disease MESH carcinogenesis
disease MESH bacterial infections
disease MESH metastasis
disease MESH pathogenesis
disease MESH hepatitis
disease MESH viral infections
pathway KEGG Cell cycle
drug DRUGBANK Aspartame
drug DRUGBANK Pentaerythritol tetranitrate
pathway KEGG Apoptosis
disease MESH carcinoma
disease MESH influenza
disease MESH papilloma
pathway KEGG p53 signaling pathway
disease MESH endometrial cancer
pathway KEGG Endometrial cancer
pathway KEGG Notch signaling pathway
disease MESH nasopharyngeal carcinoma
disease MESH lymphomas
disease MESH EBV infection
disease MESH acalculous cholecystitis
disease MESH adenocarcinoma
disease MESH infection
drug DRUGBANK Sirolimus
disease MESH gallbladder diseases
disease MESH carrier state
disease MESH colorectal cancer
pathway KEGG Colorectal cancer
disease MESH typhoid
drug DRUGBANK Coenzyme M
disease MESH noma
disease MESH bile
disease MESH Clinical relevance
disease MESH HPV infection
disease MESH gastrointestinal cancer
disease MESH anal cancer
disease MESH oral cancer

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *